The University of Chicago Header Logo

Connection

Eric Polley to Mutation

Back to Details
This is a "connection" page, showing publications Eric Polley has written about Mutation.
Eric Polley
Connection Strength
0.337
Mutation
  1. Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls. Gynecol Oncol. 2017 11; 147(2):375-380.
    View in: PubMed
    Score: 0.070
  2. Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial. J Mol Diagn. 2016 Jan; 18(1):51-67.
    View in: PubMed
    Score: 0.062
  3. Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis. J Clin Oncol. 2021 05 20; 39(15):1619-1630.
    View in: PubMed
    Score: 0.022
  4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 02 17; 12(1):1078.
    View in: PubMed
    Score: 0.022
  5. A Population-Based Study of Genes Previously Implicated in Breast Cancer. N Engl J Med. 2021 02 04; 384(5):440-451.
    View in: PubMed
    Score: 0.022
  6. Mutation prevalence tables for hereditary cancer derived from multigene panel testing. Hum Mutat. 2020 08; 41(8):e1-e6.
    View in: PubMed
    Score: 0.021
  7. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. Genet Med. 2020 02; 22(2):407-415.
    View in: PubMed
    Score: 0.020
  8. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018 08 24; 19(1):123.
    View in: PubMed
    Score: 0.019
  9. Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing. J Natl Cancer Inst. 2018 08 01; 110(8):855-862.
    View in: PubMed
    Score: 0.019
  10. Clinical Activity of the ?-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). J Clin Oncol. 2017 May 10; 35(14):1561-1569.
    View in: PubMed
    Score: 0.017
  11. New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer. Cancer Treat Rev. 2016 Apr; 45:87-96.
    View in: PubMed
    Score: 0.016
  12. Application of molecular profiling in clinical trials for advanced metastatic cancers. J Natl Cancer Inst. 2015 Apr; 107(4).
    View in: PubMed
    Score: 0.015
  13. The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res. 2013 Jul 15; 73(14):4372-82.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.